Bogle Grant C. 4
4 · Epizyme, Inc. · Filed Jun 2, 2020
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Bogle Grant C.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-05-29+14,013→ 14,013 totalExercise: $17.55Exp: 2030-05-28→ Common Stock (14,013 underlying)
Footnotes (1)
- [F1]This option will vest in full on May 29, 2021, subject to Reporting Person's continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full.